Quinazoline derivative and process for producing the same

Details for Australian Patent Application No. 2004293310 (hide)

Owner Mitsubishi Pharma Corporation

Inventors Iwamura, Hiroshi; Naka, Takashi

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2004293310

PCT Pub. Number WO2005/051924

Priority 2003-398442 28.11.03 JP

Filing date 26 November 2004

Wipo publication date 9 June 2005

International Classifications

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051924 Priority application(s): WO2005/051924

31 May 2007 Assignment before Grant

  Mitsubishi Pharma Corporation The application has been assigned to Aveo Pharmaceuticals, Inc.

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293315-Flexible polyurethane foam, process for producing the same, and automotive sheet employing the same

2004293306-Piperidine compound and process for preparing the same.